Pharmaceutical - Mergers & Acquisitions, Rest of the World

Filter

Popular Filters

CFR Pharma increases bid for Adcock Ingram which is still rejected by PIC

CFR Pharma increases bid for Adcock Ingram which is still rejected by PIC

16-12-2013

Chilean drugmaker CFR Pharmaceuticals has raised its offer price for Adcock Ingram, South Africa’s…

Adcock IngramBidvestMergers & AcquisitionsPharmaceuticalRest of the World

Bidvest aims to acquire 34.5% stake in South Africa’s Adcock Ingram, to thwart CFR bid

Bidvest aims to acquire 34.5% stake in South Africa’s Adcock Ingram, to thwart CFR bid

03-12-2013

South African conglomerate Bidvest, acting on behalf of a consortium including CIH, says it has offered…

Adcock IngramBiovest InternationalCFR PharmaceuticalsMergers & AcquisitionsPharmaceuticalRest of the WorldSouth Africa

Adcock Ingram pleads case for CFR bid; delivers strong revenue growth

Adcock Ingram pleads case for CFR bid; delivers strong revenue growth

28-11-2013

South African drugmaker Adcock Ingram yesterday made the case for accepting a takeover from Chile largest…

Adcock IngramCFR PharmaceuticalsFinancialMergers & AcquisitionsPharmaceuticalRest of the World

GlaxoSmithKline cashes in $694 million of Aspen shares

GlaxoSmithKline cashes in $694 million of Aspen shares

21-11-2013

UK pharma giant GlaxoSmithKline said yesterday that it has agreed to the sale of 28.2 million ordinary…

Aspen PharmacareFinancialGlaxoSmithKlineMergers & AcquisitionsPharmaceuticalRest of the World

GlaxoSmithKline agrees £700 million deal with Aspen

GlaxoSmithKline agrees £700 million deal with Aspen

30-09-2013

GlaxoSmithKline says it has now reached agreement to sell its thrombosis brands, Arixtra and Fraxiparine,…

ArixtraAspen PharmacareCardio-vascularFraxiparineGlaxoSmithKlineMergers & AcquisitionsPharmaceuticalRest of the World

Hikma to buy Egyptian pharma company for around $20 million

10-01-2013

Fast-growing Jordan-headquartered drugmaker Hikma Pharmaceuticals (LSE: HIK) says it has agreed to acquire…

Egyptian Company for Pharmaceuticals & ChemicGenericsHikma PharmaceuticalsMergers & AcquisitionsPharmaceuticalRest of the World

Hikma adds to stake in Promopharm; gets US appro for argatroban

22-01-2012

Fast-growing Jordan headquartered Hikma Pharmaceuticals (LSE: HIK) says that it has increased its stake…

ArgatrobanCardio-vascularGenericsHikma PharmaceuticalsMergers & AcquisitionsNorth AmericaPharmaceuticalPromopharmRegulationRest of the World

STADA pulls out of part of Grunenthal deal

04-01-2012

German drugmaker STADA Arzneimittel AG (SAZ: GR) says it has exercised its contractual right to withdraw…

EuropeGrunenthalMergers & AcquisitionsPharmaceuticalRest of the WorldSTADA Arzneimittel

Back to top